Piriprost (BioDeep_00000182472)

   

human metabolite blood metabolite


代谢物信息卡片


5-[5-hydroxy-4-(3-hydroxyoct-1-en-1-yl)-1-phenyl-1H,4H,5H,6H-cyclopenta[b]pyrrol-2-yl]pentanoic acid

化学式: C26H35NO4 (425.25659500000006)
中文名称:
谱图信息: 最多检出来源 Homo sapiens(blood) 50%

分子结构信息

SMILES: CCCCCC(O)C=CC1C(O)CC2=C1C=C(CCCCC(O)=O)N2C1=CC=CC=C1
InChI: InChI=1S/C26H35NO4/c1-2-3-5-13-21(28)15-16-22-23-17-20(12-8-9-14-26(30)31)27(24(23)18-25(22)29)19-10-6-4-7-11-19/h4,6-7,10-11,15-17,21-22,25,28-29H,2-3,5,8-9,12-14,18H2,1H3,(H,30,31)

描述信息

同义名列表

4 个代谢物同义名

5-[5-hydroxy-4-(3-hydroxyoct-1-en-1-yl)-1-phenyl-1H,4H,5H,6H-cyclopenta[b]pyrrol-2-yl]pentanoic acid; 5-[5-hydroxy-4-(3-hydroxyoct-1-en-1-yl)-1-phenyl-4H,5H,6H-cyclopenta[b]pyrrol-2-yl]pentanoic acid; 5-[5-Hydroxy-4-(3-hydroxyoct-1-en-1-yl)-1-phenyl-1H,4H,5H,6H-cyclopenta[b]pyrrol-2-yl]pentanoate; Piriprost



数据库引用编号

2 个数据库交叉引用编号

分类词条

相关代谢途径

Reactome(0)

BioCyc(0)

PlantCyc(0)

代谢反应

0 个相关的代谢反应过程信息。

Reactome(0)

BioCyc(0)

WikiPathways(0)

Plant Reactome(0)

INOH(0)

PlantCyc(0)

COVID-19 Disease Map(0)

PathBank(0)

PharmGKB(0)

1 个相关的物种来源信息

在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有：

  • PubMed: 来源于PubMed文献库中的文献信息，我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表，这个列表按照代谢物同时出现的文献数量降序排序，取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
  • NCBI Taxonomy: 通过文献数据挖掘，得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序，取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
  • Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
  • Chemical Reaction: 在化学反应过程中，存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。

点击图上的相关代谢物的名称，可以跳转到相关代谢物的信息页面。



文献列表

  • A R Mire-Sluis, C A Cox, A V Hoffbrand, R G Wickremasinghe. Inhibitors of arachidonic acid lipoxygenase impair the stimulation of inositol phospholipid hydrolysis by the T lymphocyte mitogen phytohaemagglutinin. FEBS letters. 1989 Nov; 258(1):84-8. doi: 10.1016/0014-5793(89)81621-7. [PMID: 2556300]
  • G D Leikauf, C A Doupnik, L M Leming, H E Wey. Sulfidopeptide leukotrienes mediate acrolein-induced bronchial hyperresponsiveness. Journal of applied physiology (Bethesda, Md. : 1985). 1989 Apr; 66(4):1838-45. doi: 10.1152/jappl.1989.66.4.1838. [PMID: 2543658]
  • K D Tew, A M Bomber, S J Hoffman. Ethacrynic acid and piriprost as enhancers of cytotoxicity in drug resistant and sensitive cell lines. Cancer research. 1988 Jul; 48(13):3622-5. doi: ". [PMID: 3288331]
  • I Antonipillai, J Nadler, R Horton. Angiotensin feedback inhibition on renin is expressed via the lipoxygenase pathway. Endocrinology. 1988 Apr; 122(4):1277-81. doi: 10.1210/endo-122-4-1277. [PMID: 3126033]
  • M K Bach, J O'Brien, J R Brashler, M A Johnson, D R Morton. Inhibition of rat liver glutathione S-transferases by piriprost: kinetics of the inhibition and preliminary evidence that piriprost may be a poor alternative substrate for these enzymes. Research communications in chemical pathology and pharmacology. 1985 Sep; 49(3):361-86. doi: NULL. [PMID: 3903894]
  • D M Shasby, S S Shasby, M J Peach. Polymorphonuclear leukocyte: arachidonate edema. Journal of applied physiology (Bethesda, Md. : 1985). 1985 Jul; 59(1):47-55. doi: 10.1152/jappl.1985.59.1.47. [PMID: 3928584]
  • G Feuerstein, W E Lux, D Ezra, E C Hayes, F Snyder, A I Faden. Thyrotropin-releasing hormone blocks the hypotensive effects of platelet-activating factor in the unanesthetized guinea pig. Journal of cardiovascular pharmacology. 1985 Mar; 7(2):335-40. doi: 10.1097/00005344-198503000-00020. [PMID: 2581089]
  • C E Hock, L Loprest, A M Lefer. Inhibitors of lipoxygenase products improve survival in traumatic shock. Prostaglandins. 1984 Oct; 28(4):557-71. doi: 10.1016/0090-6980(84)90244-2. [PMID: 6441186]